ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2020 American Transplant Congress

    Development of De Novo Antibody in Renal Transplant Recipients with BK Viremia Managed with Immunosuppression Reduction

    R. Hod Dvorai1, R. Lee2, P. Muluhngwi2, M. Raijmakers3, A. Shetty2, A. Tambur2, M. Ison2

    1Department of Pathology, SUNY Upstate Medical University, Syracuse, NY, 2Northwestern University, Chicago, IL, 3University of Santiago, Santiago, Chile

    *Purpose: To evaluate development of de novo donor specific antibodies (dnDSA) in Renal Transplant Recipients (RTR) with immunosuppression (IS) modulation due to BK viremia (BKV)…
  • 2020 American Transplant Congress

    Racial Disparities in Long-Term Outcomes in Kidney Transplantation from Elderly Donors in United States

    S. Shah, B. Abu Jawdeh, S. Bumb, T. Kaur, M. Anand, A. Govil, R. Jain

    University of Cincinnati, Cincinnati, OH

    *Purpose: Kidney transplantation offers survival benefit and improved quality of life in end-stage renal disease patients. Because the waiting list continues to grow, there has…
  • 2020 American Transplant Congress

    Accomplishment of Ischemia-Free Kidney Transplantation Using Normothermic Machine Perfusion

    G. Chen, X. He, C. Wang, X. Yuan, M. Han, Z. Guo

    Organ Transplant Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China

    *Purpose: Ischemia-reperfusion injury (IRI) has been considered an inevitable event in organ transplantation since the first successful kidney transplant was performed in 1954. To avoid…
  • 2020 American Transplant Congress

    In-Depth Assessment of Ischemia/Reperfusion Injury in a Murine Model of Hindlimb Transplantation

    F. Messner1, K. Kadono2, Y. Guo1, B. Oh1, J. Kupiec-Weglinski2, G. Brandacher1

    1Department of Plastic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, 2Department of Surgery, Division of Liver and Pancreas Transplantation, University of California, Los Angeles, Los Angeles, CA

    *Purpose: Static cold storage (SCS) still represents the gold standard for organ and tissue preservation in transplantation. Ischemia/reperfusion injury (IRI) that occurs due to the…
  • 2020 American Transplant Congress

    Utilization of High Terminal Creatinine Kidney Donors for Simultaneous Kidney and Pancreas Transplantation

    A. Montal, J. Torabi, N. Muhdi, J. Melvin, Y. Miura, M. Ajaimy, L. Lirano, Y. Azzi, C. Pynadath, E. Akalin, S. Greenstein, J. P. Rocca, J. A. Graham

    Montefiore Medical Center, Bronx, NY

    *Purpose: The use of kidneys with high terminal creatinine has been demonstrated in renal transplantation with excellent outcomes. Here we explore the use of high…
  • 2020 American Transplant Congress

    Novel Biomarkers for Post-Transplant Recurrent IgA Nephropathy

    Y. Caliskan1, B. Dirim2, E. Aksoy2, R. Ouseph1, Y. Ozluk3, H. Randall4, F. Savran Oguz5, A. Turkmen2, M. S. Sever2, K. Lentine1

    1Division of Nephrology, Saint Louis University, Saint Louis, MO, 2Division of Nephrology, Istanbul Faculty of Medicine, Istanbul, Turkey, 3Department of Pathology, Istanbul Faculty of Medicine, Istanbul, Turkey, 4Center for Abdominal Transplantation, Saint Louis University, Saint Louis, MO, 5Department of Medical Biology, Istanbul Faculty of Medicine, Istanbul, Turkey

    *Purpose: The aim of this study is to evaluate serum levels of galactose-deficient IgA1 (Gd-IgA1), advanced oxidation protein products (AOPP) and 4 tag single-nucleotide variants…
  • 2020 American Transplant Congress

    Caspase-1 Knockout Mice Have Increased Survival after Cold Ischemia in a Murine Kidney Transplant Model

    S. Jain1, R. Plenter2, T. Nydam2, A. Jani1

    1Renal, University of Colorado, Aurora, CO, 2Transplant Microsurgery Program, University of Colorado, Aurora, CO

    *Purpose: Prolonged cold ischemia (CI) is a known risk factor for acute kidney injury (AKI) after kidney transplantation. However, the mechanism by which CI leads…
  • 2020 American Transplant Congress

    Treg Stability Depends on Lymphotoxin Beta Receptor-Driven Migration

    V. Saxena, W. Piao, L. Li, Y. Xiong, C. Palusckievicz, T. Simon, M. Shirkey, R. Abdi, J. S. Bromberg

    University of Maryland, Baltimore, Baltimore, MD

    *Purpose: Regulatory T cell (Treg) suppressor function for allograft survival requires maintenance of transcription factor Foxp3 and sequential migration from tissues to lymph nodes (LN).…
  • 2020 American Transplant Congress

    Improved Survival of Acute Liver Failure by “Off-the-Shelf” Bioartificial Liver Support System Using Immobilized Cryopreserved Hepatocyte Spheroids in Porcine Model

    S. Lee1, J. Lee2, H. Park2, Y. Kim2, J. Noh3, J. Jung3, S. Lee3, H. Shin3, H. Yoon4, D. Lee3, S. Lee1

    1Department of Surgery, Samsung Medical Center, Seoul, Korea, Republic of, 2Stem Cell and Regenerative Medicine Center, Research Institute for Future Medicine, Samsung Medical Center, Seoul, Korea, Republic of, 3Biomedical Research Center, Lifeliver, Co. Ltd., Yongin, Korea, Republic of, 4Biomedical Research Center, Lifeliver, Co. Ltd., Seoul, Korea, Republic of

    *Purpose: Acute liver failure (ALF) has a rapid and unpredictable onset with high mortality. The only current treatment is to transplant a donor organ but…
  • 2020 American Transplant Congress

    Natural Antibodies and Left Ventricular Assist Device Complications

    S. B. See1, D. Onat2, E. Hittesdorf3, F. McDougan4, M. Yuzefpolskaya2, V. K. Topkara2, Y. Naka5, H. Takayama5, K. Takeda5, G. Milligan6, D. Wencker6, S. Hall6, M. Askar6, P. Kimball4, G. Wagener3, P. C. Colombo2, E. Zorn1

    1Columbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, NY, 2Department of Medicine, Columbia University Irving Medical Center, New York, NY, 3Department of Anesthesiology, Columbia University Irving Medical Center, New York, NY, 4Department of Transplant Surgery, Virginia Commonwealth University, Richmond, VA, 5Department of Surgery, Columbia University Irving Medical Center, New York, NY, 6Center for Advanced Heart and Lung Disease, Baylor University Medical Center, Dallas, TX

    *Purpose: Left ventricular assist device (LVAD) implantation is followed by a sharp increase in serum levels of IgG natural antibodies (Nabs) recognizing oxidation-specific epitopes (OSE)…
  • « Previous Page
  • 1
  • …
  • 53
  • 54
  • 55
  • 56
  • 57
  • …
  • 223
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences